Accuprec Research Labs Pvt. Ltd. will inaugurate dedicated building for Formulation & Development on 18th August. The event will be part of Triple Celebration that also include 6th Foundation Day of the company and Celebration of Completion of Platinum jubilee week of e-newsletter Accuprec e-Pharma Pulse. Dr. Ketan Patel, Chairman & Managing Director of Troikaa Pharmaceuticals Ltd. will be the Chief Guest of the event and Dr. Arvind Kukrety, Deputy Drug Controller of CDSCO will be the Guest of Honour of the event. On this occasion all members of Board of Advisors will be Special Guests, Shri Mulubhai Kandoriya, Managing Director of Accuprec has announced.
Formulation & Development
IHRD-ARL undertakes formulation development of Pharmaceuticals ranging from immediate release formulations for oral administration to alternative dosage designs and controlled release formulations, aided by state-of-the-art technology and equipments. Formulation designs include Ethical Products.
Pharmaceutical Formulation Development:
Solid oral
Topical dosage form
Parenterals
Activities planned:
Literature Information & Primary Patent Status Evaluation
Preformulation study
Prototype Formulation Development
Packaging Development
Scale-up of selected Prototype Formulation
Process Optimization
Process Validation
Manufacture of Exhibit/Bio-batch
Bio-Equivalence Study
Product Development Report
Documentation in CTD Format
Technology Transfer
Stability Study